GlassScriptPhysician profile
Lauren Roderick
NPI 1841545381
$1,095.07
in general payments reported to CMS, 2019-2025
22 companies · $400 in 2025
The $400 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $82.01 · 2021: $93.91 · 2022: $77.95 · 2023: $86.28 · 2024: $197 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $683.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $196.83 | 2019-2025 | Precision7, Rocklatan |
| Rxsight INC | $173.98 | 2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
| Coopervision INC. | $82.72 | 2019-2023 | Misight Contact Lens |
| Biotissue Holdings INC. | $80.54 | 2022-2025 | |
| Tarsus Pharmaceuticals, INC. | $70.82 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $59.95 | 2019-2024 | |
| Bausch & Lomb Americas INC. | $52.17 | 2024-2025 | Miebo, Vyzulta, Xiidra |
| Allergan, INC. | $47.80 | 2019-2022 | |
| Abbvie INC. | $45.36 | 2023-2024 | Lumigan, Alphagan P |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $44.83 | 2019 | |
| Novartis Pharmaceuticals Corporation | $34.74 | 2020-2021 | |
| Kala Pharmaceuticals, INC. | $31.88 | 2019-2021 | |
| Tearlab Corp | $26.30 | 2019-2024 | Scoutpro Osmolarity System |
| Thea Pharma INC. | $21.99 | 2022 | |
| Amgen INC. | $21.60 | 2024 | Tepezza |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $18.66 | 2020 | |
| Oyster Point Pharma, INC. | $18.62 | 2023 | Tyrvaya |
| Johnson & Johnson Vision Care, INC. | $15.42 | 2024 | |
| New World Medical,INC. | $13.39 | 2023 | |
| Johnson & Johnson Surgical Vision, INC. | $13.33 | 2021 | |
| Aerie Pharmaceuticals, INC. | $12.61 | 2019 | |
| Shire North American Group INC | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Roderick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.